Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
How Do We Choose an Appropriate Therapy for Macular Edema in Patients With Retinal Vein Occlusions in the Absence of Head-to-Head Clinical Trials?
Faculty
Jeffrey S. Heier, MD
Ophthalmic Consultants of Boston
Boston, Massachusetts
Accredited by
University of New Mexico Health Sciences Center, School of Medicine
View Activity Materials
Activity Details
| Credit Types: | CME |
| Credit Amount: | 0.5 Credits |
| Release Date: | 2011-Jun-30 |
| Expiration Date: | 2012-Jun-29 |
| Estimated Time for Completion: | 30 minutes |
| Registration Required: | No |
| Cost: | Free |
Program Description & Educational Objectives
In this activity, a concise overview of recent efficacy and safety data with respect to the treatment of macular edema secondary to branch and central retinal vein occlusion is provided. Topics discussed include laser grid photocoagulation therapy, intravitreal corticosteroids, and intravitreal antivascular endothelial growth factor therapies. In addition, Dr. Jeffrey Heier comments on the challenges many clinicians face with respect to treatment selection in patients with these conditions due to a lack of head-to-head clinical trials. He also discusses some potential strategies to aid practitioners in selecting an appropriate therapy for patients with macular edema secondary to retinal vein occlusion.
Upon completion of this activity, participants should be better able to:
- Apply recent efficacy and safety data related to intravitreal therapies for the treatment of macular edema secondary to retinal vein occlusion
- Develop algorithms for the selection of treatment for individual patients with macular edema secondary to retinal vein occlusion
Target Audience
This activity has been designed to meet the educational needs of ophthalmologists, retina specialists, and other clinicians involved in the management of patients with macular edema secondary to retinal vein occlusion.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Internet
Release and Expiration Dates: June 30, 2011 - June 29, 2012
Time to Complete: 30 minutes
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, the University of New Mexico Health Sciences Center, School of Medicine, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by UNM CME and conflicts of interest were resolved prior to the activity.
Editorial Reviewer
Jeffrey S. Heier, MD
Ophthalmic Consultants of Boston
Boston, Massachusetts
Jeffrey S. Heier, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Alcon, Inc.; Alimera Sciences; Allergan, Inc.; Fovea Pharmaceuticals SA; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.
Advisory Board for Alcon, Inc.; Alimera Sciences; Allergan, Inc.; Fovea Pharmaceuticals SA; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.
Content Director
Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education
Kirk A. Tacka, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of New Mexico Health Sciences Center, School of Medicine and PVI, PeerView Institute for Medical Education. The University of New Mexico Health Sciences Center, School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of New Mexico Health Sciences Center, School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity is jointly sponsored by the University of New Mexico Health Sciences Center, School of Medicine and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from Genentech, Inc.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
